Anterior ischemic optic neuropathy. 2012

Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri

UI MeSH Term Description Entries
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068258 Bevacizumab An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS. Avastin,Bevacizumab-awwb,Mvasi,Bevacizumab awwb
D014222 Triamcinolone Acetonide An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. Azmacort,Cinonide,Kenacort A,Kenalog,Kenalog 40,Tricort-40,Acetonide, Triamcinolone,Tricort 40,Tricort40
D014792 Visual Acuity Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast. Acuities, Visual,Acuity, Visual,Visual Acuities
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D058449 Intravitreal Injections The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe. Injection, Intravitreal,Injections, Intravitreal,Intravitreal Injection
D061067 Antibodies, Monoclonal, Humanized Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab. Antibodies, Humanized,Humanized Antibodies
D018917 Optic Neuropathy, Ischemic Ischemic injury to the OPTIC NERVE which usually affects the OPTIC DISK (optic neuropathy, anterior ischemic) and less frequently the retrobulbar portion of the nerve (optic neuropathy, posterior ischemic). The injury results from occlusion of arterial blood supply which may result from TEMPORAL ARTERITIS; ATHEROSCLEROSIS; COLLAGEN DISEASES; EMBOLISM; DIABETES MELLITUS; and other conditions. The disease primarily occurs in the sixth decade or later and presents with the sudden onset of painless and usually severe monocular visual loss. Anterior ischemic optic neuropathy also features optic disk edema with microhemorrhages. The optic disk appears normal in posterior ischemic optic neuropathy. (Glaser, Neuro-Ophthalmology, 2nd ed, p135) Anterior Ischemic Optic Neuropathy,Ischemic Optic Neuropathy,NAION,Nonarteritic Anterior Ischemic Optic Neuropathy,Optic Ischaemic Neuropathy,Optic Ischemic Neuropathy,Optic Nerve Ischemia,Posterior Ischemic Optic Neuropathy,Optic Neuropathy, Anterior Ischemic,Optic Neuropathy, Posterior Ischemic,Ischaemic Neuropathy, Optic,Ischemia, Optic Nerve,Ischemic Neuropathy, Optic,Ischemic Optic Neuropathies,Nerve Ischemia, Optic,Neuropathy, Ischemic Optic,Neuropathy, Optic Ischaemic,Neuropathy, Optic Ischemic,Optic Ischaemic Neuropathies,Optic Ischemic Neuropathies,Optic Nerve Ischemias

Related Publications

Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
May 1985, American journal of ophthalmology,
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
June 1995, Insight (American Society of Ophthalmic Registered Nurses),
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
January 1983, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
September 1995, Seminars in ophthalmology,
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
April 1994, Ceskoslovenska oftalmologie,
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
January 1997, Clinical neuroscience (New York, N.Y.),
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
December 2007, Ophthalmology,
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
November 1981, Archives of neurology,
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
December 2002, Current opinion in ophthalmology,
Morteza Entezari, and Alireza Ramezani, and Mohammad Pakravan, and Ali Mahmoodi, and Hossein Hassanpour, and Mehdi Yaseri
February 2005, Journal of clinical hypertension (Greenwich, Conn.),
Copied contents to your clipboard!